Merrimack Pharmaceuticals (MACK) Earnings Date, Estimates & Call Transcripts → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free MACK Stock Alerts $15.03 +0.05 (+0.33%) (As of 05/2/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMar. 7EstimatedActual EPS (Mar. 7) -$0.01 Missed By -$0.01 Get Merrimack Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for MACK and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMACK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MACK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… MACK Earnings Date and InformationMerrimack Pharmaceuticals last posted its earnings data on March 7th, 2024. The biopharmaceutical company reported ($0.01) earnings per share for the quarter. Merrimack Pharmaceuticals has generated ($0.08) earnings per share over the last year (($0.08) diluted earnings per share). Read More Merrimack Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/7/2024Q4 2023-($0.01)($0.01)($0.01)--11/2/2023Q3 2023-($0.02)($0.02)($0.02)--8/3/2023Q2 2023-($0.03)($0.03)($0.03)--5/4/2023Q1 2023-($0.02)($0.02)($0.02)--3/9/2023Q4 2022-($0.03)($0.03)($0.03)--11/3/2022Q3 2022-($0.03)($0.03)($0.03)-- Get the Latest News and Ratings for MACK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merrimack Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022-($0.04)($0.04)($0.04)--5/5/2022Q1 2022-($0.04)($0.04)($0.07)--3/9/2022Q4 2021-($0.03)($0.03)($0.03)--11/4/2021Q3 2021-($0.04)($0.04)($0.04)--8/5/2021Q2 2021-($0.06)($0.06)($0.06)--5/6/2021Q1 2021-($0.05)($0.05)($0.05)-- Merrimack Pharmaceuticals Earnings - Frequently Asked Questions When did Merrimack Pharmaceuticals announce their last quarterly earnings? Merrimack Pharmaceuticals (NASDAQ:MACK) last announced its quarterly earning data on Thursday, March 7, 2024. Learn more on MACK's earnings history. How much profit does Merrimack Pharmaceuticals generate each year? Merrimack Pharmaceuticals (NASDAQ:MACK) has a recorded net income of -$1.18 million. MACK has generated -$0.08 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Rigel Pharmaceuticals Earnings Date Verastem Earnings Date Vanda Pharmaceuticals Earnings Date Regulus Therapeutics Earnings Date XOMA Earnings Date Emergent BioSolutions Earnings Date Lexicon Pharmaceuticals Earnings Date Prelude Therapeutics Earnings Date Generation Bio Earnings Date G1 Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: PayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting Season This page (NASDAQ:MACK) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsThe A.I. story nobody is telling you (Read ASAP)TradeSmithCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryDid You Get Your Free Bitcoin Yet?Crypto Swap Profits$5,000 Gold?Stansberry ResearchREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merrimack Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.